Breast sentinel node imaging with low-dose SPECT/CT

Nuclear Medicine Communications

Volumn 31, Issue 2, 2010, Pages 107-111

  Coffey, J P ^a   Hill, J C ^a  

^a ROYAL PRESTON HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Sentinel node imaging; Single photon emission computed tomography computed tomography

Indexed keywords

TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AGED; ARTICLE; AXILLA; BREAST CARCINOMA; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; FALSE NEGATIVE RESULT; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; INTRAOPERATIVE PERIOD; LUNG CARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; MUCINOUS CARCINOMA; SENTINEL LYMPH NODE BIOPSY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; RADIATION DOSAGE; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 75149127737     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32832ed3a6     Document Type: Article

References (30)

1. Gallowitsch HJ, Kraschl P, Igerc I, Hussein T, Kresnik E, Mikasch P, et al. Sentinel node SPECT-CT in breast cancer. Can we expect any additional and clinically relevant information. Nuklearmedizin 2007; 46:252-256.
2. Kim W, Menda Y, Willis J, Bartel T, Graham M. Use of lymphosicintigraphy with SPECT/CT for sentinel node localization in a case of vaginal melanoma. Clin Nucl Med 2006; 31:201-202.
3. Khafif A, Schneebaum S, Fliss DM, Lerman H, Metser U, Ben Yosef R, et al. Lymphoscintigraphy for sentinel node mapping using a hybrid single photon emission CT (SPECT)/CT system in oral cavity squamous cell carcinoma. Head Neck 2006; 28:874-879.
4. Kizu H, Takayama T, Fukuda M, Egawa M, Tsushima H, Yamada M, et al. Fusion of SPECT and multidetector CT images for accurate localization of pelvic sentinel lymph nodes in prostate cancer patients. J Nucl Med Technol 2005; 33:78-82.
5. Sherif A, Garske U, de la Torre M, Thron M. Hybrid SPECT-CT: an additional technique for sentinel node detection of patients with invasive bladder cancer. Eur Urol 2006; 50:83-91.
6. Schillaci O, Danieli R, Manni C, Simonetti G. Is SPECT/CT with a hybrid camera useful to improve scintigraphic imaging interpretation? Nucl Med Commun 2004; 25:705-710.
7. Husarik DB, Steinert HC. Single photon emission computed tomography/ computed tomography for sentinel node mapping in breast cancer. Semin Nucl Med 2007; 37:29-33.
8. Lerman H, Metser U, Lievshitz G, Sperber F, Shneebaum S, Even-Sapir E. Lymphscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT/CT. Eur J Nucl Med Mol Imaging 2006; 33:329-337.
9. Kretschmer L, Altenvoerde G, Meller J, Zutt M, Funke M, Neumann C, Becker W. Dynamic lymphoscintigraphy and image fusion of SPECT and pelvic CT-scans allow mapping of aberrant pelvic sentinel lymph nodes in malignant melanoma. Eur J Cancer 2003; 39:175-183.
10. Wagner A, Schicho K, Glaser C, Zettinig C, Yerit K, Lang S, et al. SPECT/CT for topographic mapping of sentinel lymph nodes prior to gamma probe-guided biopsy in head and neck squamous cell carcinoma. J Craniomaxillofac Surg 2004; 32:343-349.
11. Ishihara T, Kaguchi A, Matsushita S, Shiraishi S, Tomiguchi S, Yamashita Y, et al. Management of sentinel lymph nodes in malignant skin tumors using dynamic lymphoscintigraphy and the single photon-emission computed tomography/computed tomography combined system. Int J Clin Oncol 2006; 11:214-220. (Pubitemid 44087120)
12. Van der Ploeg IMC,Valdes Olmos RA, Nieweg OE, Rutgers EJTh, Kroon BBR, Hoefnagel CA. The additional value of SPECT/CT in lymphatic mapping in breast cancer and melanoma. J Nucl Med 2007; 48:1756-1760.
13. McMasters KM,Wong SL, Tuttle TM, Carlson DJ, Brown CM, Dirk Noyes R, et al. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg 2000; 231:724-731.
14. Kern KA, Rosenberg RJ. Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareaolar injection of technetium 99m sulfur colloid. J Am Coll Surg 2000; 191:479-489.
15. Clarke D, Newcombe RG, Mansel RE. The learning curve in sentinel node biopsy: the ALMANAC experience. Ann Surg Oncol 2004; 11:S211-S215.
16. Nieweg OE, Estourgie SH. What is a sentinel node and what is a false-negative sentinel node? Ann Surg Oncol 2004; 11:129S-173S.
17. Quan ML, McCready D, Temple WJ, McKinnon JG. Biology of lymphatic metastases in breast cancer: lessons learned from sentinel node biopsy. Ann Surg Oncol 2002; 9:467-471.
18. Torrenga H, Meijer S, Fabry H, Van der Sijp J. Sentinel node biopsy in breast cancer patients: triple technique as a routine procedure. Ann Surg Oncol 2004; 11:231S-235S.
19. Choi SH, Barsky SH, Chang HR. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer. Breast J 2003; 9:153-162.
20. Takahashi M, Sasa M, Hirose C, Hisaoka S, Taki M, Hirose T, Bando Y. Clinical efficacy and problems with CT lymphography in identifying the sentinel node in breast cancer. World J Surg Oncol 2008; 6:1477-1478.
21. Suga K, Ogasawara N, Okada M, Matsunaga N. Interstitial CT lymphography guided localization of breast sentinel lymph node: preliminary results. Surgery 2003; 133:170-179.
22. Suga K, Ogasawara N, Yuan Y, Okada M, Matsunaga N, Tangoku A. Visualization of breast lymphatic pathways with an indirect computed tomography lymphgraphy using a nonionic monometric contrast medium iopamidol: preliminary results. Invest Radiol 2003; 38:73-84.
23. Veronesi U, De Cicco C, Galimberti VE, Fernandez JR, Rotmensz N, Viale G, et al. A Comparative study of the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol 2007; 18:473-478.
24. Crippa F, Gerali A, Alessi A, Agresti R, Bombardieri F. FDG PET for axillary lymph node staging in primary breast cancer. Eur J Nuc Med Mol Imaging 2004; 31:S97-S102.
25. Heusner TA, Kuemmel S, Umuthu L, Koeninger KR, Freudenberg LS, Hauth FA, et al. Breast cancer staging in a single session whole body PET/ CT mammography. J Nuc Med 2008; 49:1215-1222.
26. Susnik B, Frkovic-Grazio S, Bracko M. Occult micrometastases in axillary lymph nodes predict subsequent distant metastses in stage 1 breast cancer: a case-control study with 15 year follow-up. Ann Surg Oncol 2004; 11:568-572.
27. Langer I, Marti WR, Guller U, Moch H, Harder F, Oertli D, Zuber M. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg 2005; 241:152-158.
28. Cox CE, Kiluk JV, Riker AI, Cox JM, Allred N, Ramos DC, et al. Significance of sentinel lymph node micrometastases in human breast cancer. J Am Coll Surg 2008; 206:261-268.
29. Sawyer LJ, Staritt HC, Hiscock SC, Evans MJ. Effective doses to patients form CTacquisitions on the GE Infinia Hawkeye: a comparison of calculation methods. Nucl Med Comm 2008; 29:144-149.
30. X-ray dose information; X ray dose to the patient. Infinia - Nuclear Medicine Imaging System. User's guide 2003; B18-19.